Jeffrey M Witkin

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 3

Top Topics

Top Venues

Drug development research

Biopharmaceutics & drug disposition

ACS chemical neuroscience

This page only lists publications with an associated author ORCID identifier.

Publications

Xingjie Ping, Michelle J Meyer, Nicolas M Zahn, Lalit K Golani, Dishary Sharmin, Kamal P Pandey, Sepideh Revanian, Prithu Mondal, Xiaoming Jin, Leggy A Arnold, Rok Cerne, James M Cook, Branka Divović, Miroslav M Savić, Arnold Lippa, Jodi L Smith, Jeffrey M Witkin
Comparative anticonvulsant activity of the GABAkine KRM-II-81 and a deuterated analog. Drug development research (2023)
Lalit K Golani, Branka Divović, Dishary Sharmin, Kamal P Pandey, Md Yeunus Mian, Rok Cerne, Nicolas M Zahn, Michelle J Meyer, Veera V N P B Tiruveedhula, Jodi L Smith, Xingjie Ping, Xiaoming Jin, Arnold Lippa, Jeffrey M Schkeryantz, Leggy A Arnold, James M Cook, Miroslav M Savić, Jeffrey M Witkin
Metabolism, pharmacokinetics, and anticonvulsant activity of a deuterated analog of the α2/3-selective GABAkine KRM-II-81. Biopharmaceutics & drug disposition 43 (2) (2022)
Daniel E Knutson, Jodi L Smith, Xingjie Ping, Xiao-Ming Jin, Lalit K Golani, Guanguan Li, Veera Venkata Naga Phani Babu Tiruveedhula, Farjana Rashid, Md Yeunus Mian, Rajwana Jahan, Dishary Sharmin, Rok Cerne, James M Cook, Jeffrey M Witkin
Imidazodiazepine Anticonvulsant, KRM-II-81, Produces Novel, Non-diazepam-like Antiseizure Effects. ACS chemical neuroscience 11 (17) (2020)